Breeding companies are leaving Europe due to CRISPR-Cas ruling

Research assignments that are being withdrawn, companies that are deciding to relocate their R&D departments outside Europe — it is gradually becoming clear that the decision by the European Court of Justice to treat CRISPR-Cas as a form of genetic modification is having far-reaching consequences. Including for WUR.

This summer, the European Court of Justice ruled that the technique CRISPR-Cas, which allows very precise changes to be made to the DNA of bacteria, plants and animals, should fall under the strict laws for genetically modified organisms (GMOs). This means that crops that were improved using CRISPR-Cas have to undergo a time-consuming and expensive approval procedure before they can be grown or traded. In countries such as the US and Japan, CRISPR-Cas is not covered by that GMO procedure so plant breeders can now develop and market new varieties much faster there. The court’s decision will put the Dutch plant breeding sector at a disadvantage, concludes Ernst van den Ende, director of the Plant Sciences Group.

Read more at Wageningen University & Research (Albert Sikkema)

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.